Resveratrol and Diabetic Cardiomyopathy: Focusing on the Protective Signaling Mechanisms

Abstract EN

Diabetic cardiomyopathy (DCM) is a common cardiovascular complication of diabetic mellitus that is characterized by diastolic disorder in the early stage and clinical heart failure in the later stage.

Presently, DCM is considered one of the major causes of death in diabetic patients.

Resveratrol (RSV), a naturally occurring stilbene, is widely reported as a cardioprotective substance in many heart diseases.

Thus far, the specific roles of RSV in DCM prevention and treatment have attracted great attention.

Here, we discuss the roles of RSV in DCM by focusing its downstream targets from both in vivo and in vitro studies.

Among such targets, Sirtuins 1/3 and AMP-activated kinase have been identified as key mediators that induce cardioprotection during hyperglycemia.

In addition, many other signaling molecules (e.g., forkhead box-O3a and extracellular regulated protein kinases) are also regulated in the presence of RSV and exert beneficial effects such as opposing oxidative stress, inflammation, and apoptosis in cardiomyocytes exposed to high-glucose conditions.

The beneficial potential of an RSV/stem cell cotherapy is also reviewed as a promising therapeutic strategy for preventing the development of DCM.